News From The Obesity Research Group
Posted: Plays: 68,333

(Watch Video)

Clinical research involving thousands of women and men has revealed a surprising truth: the key difference between overweight and lean individuals isn't simply about calorie intake or restrictive diets. Instead, it hinges on the presence of what leading scientists call "chemical obesogens."

These obesogens accumulate in your body over time, with their levels increasing as you age. They disrupt your body's natural processes, making it harder to shed excess fat, no matter how much you exercise or how carefully you watch your diet.

For most people, eliminating these chemical obesogens is the hidden secret to achieving rapid and sustained fat loss. Addressing them can unlock your body's ability to burn fat effectively—regardless of your age or medical condition.

Recently, a breakthrough has emerged, combining this knowledge with the use of medications like semaglutide. Originally developed to help manage blood sugar levels, semaglutide has shown incredible potential for weight loss by curbing appetite and addressing fat storage at its source. This approach, paired with a simple night-time routine, can amplify your results. It primes your body to burn even the most stubborn fat while you sleep, targeting deep fat stores resistant to diet and exercise.

This discovery is shaking the foundations of the billion-dollar weight loss industry, which is desperate to suppress this game-changing revelation. Don't miss your chance to learn about this revolutionary method while the information is still available.

Tap "Watch Now" to uncover how you can harness this extraordinary breakthrough and transform your body.

Scientific References:

• Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 2005 Jan 5;293(1):43-53. doi: 10.1001/jama.293.1.43.
• Thorogood A, Mottillo S, Shimony A, Filion KB, Joseph L, Genest J, Pilote L, Poirier P, Schiffrin EL, Eisenberg MJ Isolated aerobic exercise and weight loss: a systematic review and meta-analysis of randomized controlled trials Am J Med 2011 Aug;124(8):747-55. doi: 10.1016/j.amjmed.2011.02.037.
• Jacobson MH, Woodward M, Bao W, Liu B, Trasande L Urinary Bisphenols and Obesity Prevalence Among U.S. Children and Adolescents J Endocr Soc 2019 Jul 25;3(9):1715-1726. doi: 10.1210/js.2019-00201.
• Yuan X, Wei G, You Y, Huang Y, Lee HJ, Dong M, Lin J, Hu T, Zhang H, Zhang C, Zhou H , Ye R, Qi X, Zhai B, Huang W, Liu S, Xie W, Liu Q, Liu X, Cui C, Li D, Zhan J, Cheng J, Yuan Z, Jin W Rutin ameliorates obesity through brown fat activation FASEB J 2017 Jan;31(1):333-345. doi: 10.1096/fj.201600459RR.
• Carwile et al. Use of Polycarbonate Bottles and Urinary Bisphenol A Concentrations. Environmental Health Perspectives, May 12, 2009; DOI: 10.1289/ehp.0900604.
• Carwile JL, Michels KB Urinary bisphenol A and obesity: NHANES 2003-2006. Environ Res 2011 Aug;111(6):825-30. doi: 10.1016/j.envres.2011.05.014.
• Sharma S, Chatterjee S Microplastic pollution, a threat to marine ecosystem and human health: a short review. Environ Sci Pollut Res Int. 2017 Sep;24(27):21530-21547.
• Cox KD, Covernton GA, Davies HL, Dower JF, Juanes F, Dudas SE Human Consumption of Microplastics. Environ Sci Technol. 2019 Jun 18;53(12):7068-7074. doi: 10.1021/acs.est.9b01517.
• Thompson RC, Moore CJ,2 Saal FSV, Swan SH Plastics, the environment and human health: current consensus and future trends. Philos Trans R Soc Lond B Biol Sci. 2009 Jul 27; 364(1526): 2153–2166.
• Do Minh, Chang Vicky C, Mendez Michelle A, de Groh Margaret Urinary bisphenol A and obesity in adults: results from the Canadian Health Measures Survey. Health Promot Chronic Dis Prev Can. 2017 Dec; 37(12): 403–412.
• Kim KY, Lee E, Kim Y The Association between Bisphenol A Exposure and Obesity in Children—A Systematic Review with Meta-Analysis. Int J Environ Res Public Health. 2019 Jul; 16(14): 2521.